Effects of apoA-II, C-I, C-II on in vivo metabolism of apoB-containing lipoproteins-stable, isotope study
Effects of apoA-II, C-I, C-II on in vivo metabolism of apoB-containing lipoproteins-stable, isotope study
批准号:
14571110
负责人:
IKEWAKI Katsunori
金额:
$1.73万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
除了ldl -胆固醇(C)升高外,富含甘油三酯(TG)的脂蛋白升高作为冠状动脉疾病的风险引起了更多的关注。富tg脂蛋白(TRL)包括异质脂蛋白亚类,取决于载脂蛋白组成。其中apoC-III和apoE已被广泛研究,而其他凋亡蛋白如apoA-II、C-I、C-II的作用在很大程度上是未知的。在本研究中,我们希望利用稳定同位素标记的氨基酸示踪剂研究1)载脂蛋白组成不同的VLDL亚类的分布,2)apoC-III和apoE在体内的作用。含有VLDL的ApoA-II、C-I和C-II分别占VLDL的13%、17%和16%,与含有apoC-III或apoE的相比,在TRL中所占的比例较小。含有载脂蛋白的颗粒含有更多的胆固醇和TG,并且往往含有其他载脂蛋白。餐后分布不改变,但绝对浓度随着脂肪摄入而增加。体内动力学研究表明,E-/C和E-/C+ VLDL的分解代谢速度比E+/C和E+/C+颗粒快。IDL和LDL也是如此。含有ApoE的颗粒,特别是E+/C-,通过LDL受体或/和LRP直接分解代谢,并延迟脂解。相反,E-/C和E-/C+颗粒催化有利于脂肪分解而不是直接去除。综上所述,这些结果表明:1)与apoC-III和apoE不同,含有apoA-II、apoC-I或apoC-II的TRL所占比例较小,不适合进行动力学研究。稳定同位素示踪研究与免疫亲和分离技术的结合,首次揭示了apoC-III和apoE对TRL的作用,即抑制脂解作用,促进apoE的直接摄取,促进apoC-III的脂解作用。
英文摘要
In addition to an elevated LDL-cholesterol (C), an increased triglyceride (TG) rich lipoprotein has drawn more attention as the risk for coronary artery disease. TG-rich lipoproteins (TRL) comprise heterogeneous lipoproteins subclasses, depending upon apoprotein composition. Among them, apoC-III and apoE have been extensively investigated, whereas effects of other apoptoteins such as apoA-II, C-I, C-II are largely unknown. In the present study, we wish to investigate 1) distribution of VLDL subcleasses which differ in apolipoprotein compositions, 2) in vivo role of apoC-III and apoE by utilyzing stable isotopically labeled amino acid tracer study. ApoA-II, C-I, and C-II containing VLDL comprise 13%, 17%, and 16% of VLDL, respectively, representing minor fractions among TRL relative to those containing either apoC-III or apoE. Those containing the apolipoproteins comprise more cholesterol and TG per particle and tend to have other apoproteins. Distribution does not change postprandially, but absolute concentrations increase by fat ingestion. In vivo kinetic study revealed that E-/C-and E-/C+ VLDL are catabolized faster than E+/C-and E+/C+ particles. This was true for IDL and LDL, too. ApoE containing particle, especially E+/C-, are preferentially catabolized by direct removal via LDL receptor or/and LRP with a delayed lipolysis. To the contrary, E-/C-and E-/C+ particles are catablized in favor of lipolysis rather than direct removal. In conclusions, these results demonstrated 1) that, unlike apoC-III and apoE, TRL containing apoA-II, apoC-I, or apoC-II represent minor fraction, thus not suitable for kinetic study. Combination of stable isotope tracer study with immunoaffinity isolation technique provides for the first time a new insight into the role of apoC-III and apoE on TRL, namely inhibitory effect of lipolysis and promoting direct uptake by apoE and promoting lipolysis by apoC-III.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Keio Okubo: "Abnormal high density lipoprotein apoliprotein A-I and A-Il kinetics in hemodialysis patients -a stable isotope study."American Journal of Society of Nephrology. (in press).
Keio Okubo:“血液透析患者中异常的高密度脂蛋白载脂蛋白 A-I 和 A-II 动力学 - 一项稳定同位素研究。”美国肾脏病学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katsunori Ikewaki: "Effect of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia-a nuclear magnetic resonance study"International Journal of Cardiology. (in press).
Katsunori Ikewaki:“苯扎贝特对高甘油三酯血症患者脂蛋白亚类和炎症标志物的影响——一项核磁共振研究”《国际心脏病学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Keio Okubo: "Abnormal high density lipoprotein apoliprotein A-I and A-II kinetics in hemodialysis patients - a stable isotope study."American Journal of Society of Nephrology. (in press). (2004)
Keio Okubo:“血液透析患者的异常高密度脂蛋白载脂蛋白 A-I 和 A-II 动力学 - 一项稳定同位素研究。”美国肾脏病学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katsunori Ikewaki: "Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia - a nuclear magnetic resonance study"International Journal of Cardiology. (in press). (2004)
Katsunori Ikewaki:“苯扎贝特对高甘油三酯血症患者脂蛋白亚类和炎症标志物的影响 - 核磁共振研究”国际心脏病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katsunori Ikewaki: "Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertrigly-ceridemia-a nuclear magnetic resonance study."International Journal of Cardiology. (in press).
Katsunori Ikewaki:“苯扎贝特对高甘油三酯血症患者脂蛋白亚类和炎症标志物的影响 - 一项核磁共振研究。”国际心脏病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Effects of statin on apolipoprotein metabolism in patients with hemodialysis
-
批准号:22591002
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:IKEWAKI Katsunori
-
依托单位:
Inter-relationship between lipoprotein and glucose metabolism-analysis using stable isotope study
-
批准号:17590949
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2005
-
负责人:IKEWAKI Katsunori
-
依托单位:
In vivo evidence of a delayed catabolism of remnant and decreased production of apoA-I in patients with chronic renal failure. -A stable isotope study.
-
批准号:11671054
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1999
-
负责人:IKEWAKI Katsunori
-
依托单位:
海外基金